Next Article in Journal
Dipeptide Extract Modulates the Oxi-Antioxidant Response to Intense Physical Exercise
Next Article in Special Issue
Dietary Supplements in People with Metastatic Cancer Who Are Experiencing Malnutrition, Cachexia, Sarcopenia, and Frailty: A Scoping Review
Previous Article in Journal
Cross-Sectional Associations of Intakes of Starch and Sugars with Depressive Symptoms in Young and Middle-Aged Japanese Women: Three-Generation Study of Women on Diets and Health
Previous Article in Special Issue
The Effect of Exercise and Nutritional Interventions on Body Composition in Patients with Advanced or Metastatic Cancer: A Systematic Review
 
 
Review
Peer-Review Record

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis

Nutrients 2022, 14(12), 2403; https://doi.org/10.3390/nu14122403
by Megan Crichton 1,*, Patsy M. Yates 1, Oluwaseyifunmi Andi Agbejule 2, Amy Spooner 1, Raymond J. Chan 1,2 and Nicolas H. Hart 1,2,3,4
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Nutrients 2022, 14(12), 2403; https://doi.org/10.3390/nu14122403
Submission received: 12 May 2022 / Revised: 12 May 2022 / Accepted: 7 June 2022 / Published: 9 June 2022
(This article belongs to the Special Issue Role of Diet and Exercise for Advanced and Metastatic Cancers)

Round 1

Reviewer 1 Report

This  systematic review and meta-analysise is carefully conducted using the correct procedures. Quality assurance is also well controlled. I believe that these evidences will help people with advanced cancer.

Reviewer 2 Report

In the present review “Non-pharmacological self-management strategies for chemotherapy-induced peripheral neuropathy in people with advanced cancer: A systematic review and meta-analysis”, Megan Crichton and colleagues sought to determine the effect of non-pharmacological self-management interventions on the incidence and severity of chemotherapy-induced peripheral neurotherapy (CIPN) symptoms and CIPN-related outcomes (quality of life, physical function, sleep, fatigue, gastrointestinal symptoms, nutrition status, psychosocial and financial outcomes, and adverse effects) compared to any control condition. So far, they concluded that the strongest evidence with the most certainty was found for physical exercise as a safe and viable adjuvant to chemotherapy treatment for the prevention and management of CIPN and related physical function in people with advanced cancer. Moreover, nutrition supplements of glutamine and an Omega-3 PUFA-enriched drink showed some benefit, and the use of interactive technology may facilitate education for self-management of CIPN; however, certainty in these effects was very low. Of course, future clinical trials should be rigorously designed and reported to include adequate sample size, clearly defined populations, and interventions, and use valid outcome measures. Overall, I think that the manuscript is intriguing, well-written (within the scope of this journal), well-structured and the data are of clinical relevance on a current topic of interest. I would like to congratulate the authors on their work.

Back to TopTop